College of Pharmacy
Graduates Pass 2022 NAPLEX Exam at 96% Rate
The Jefferson College of Pharmacy congratulates the PharmD Class of 2022 with >96% of graduates passing the North American Pharmacist Licensing Exam (NAPLEX) on their first attempt. The first-attempt pass rate for all graduates of Pennsylvania colleges of pharmacy was 82% and the national first-attempt pass rate was 80%. Since the first JCP PharmD graduating class in 2012, the first-attempt passing rate of JCP graduates has exceeded 90% each year. In addition, 97% of the Class of 2022 who participated in the ASHP residency matching program matched to a post-graduate residency as compared to the national average of 77%.
Our formula for success = engaged students + effective curriculum + dynamic faculty + dedicated preceptors
For more evidence of our success, visit our Doctor of Pharmacy Program Outcomes page.
Jefferson College of Pharmacy ranked by U.S. News as a Best Graduate School
Jefferson College of Pharmacy is proud to be ranked by U.S. News as a top pharmacy program in the country.
For the past 12 years, JCP has been preparing students to tackle challenges in drug discovery and development, disparities in health care access and quality and other complex societal issues including the opioid crisis.
The core values of the program are deeply rooted in developing pharmacists with a sense of social, personal and professional responsibility.
JCP Certificate Programs
Jefferson College of Pharmacy will host the American Pharmacists Association’s and National Association of Chain Drug Stores' Certificate Programs.
JCP has an active student community and provides the resources they need to plan and succeed during their education.
JCP is well-recognized among schools and colleges of pharmacy for our innovative and comprehensive approach to Interprofessional Education.
Jefferson College of Pharmacy hosts Certificate training programs.
Jefferson College of Pharmacy Research
We're dedicated to collaborative research initiatives that focus on disease etiology, development of novel therapies, drug outcomes and their economic impact and enhanced patient care.